Gene Therapy Market

Gene Therapy Market Segment Analysis

Gene therapy market is segmented on the basis of vector type, gene type, application and by region. The market is divided into two types of vectors: viral vector and nonviral vector. Due to easy modifications of various viruses such as Lentivirus, Adeno-Associated Virus (AAV), Retrovirus, and Gamma Retrovirus to deliver gene therapy medications, as well as improvements in DNA, RNA, and oncolytic viral vectors gene therapy, the viral vector sector contributed the most to market growth. However, due to advancements in physicochemical approaches such as physical methods and chemical methods of nonviral vector for gene therapies during preclinical and clinical trials for the treatment of various diseases, the nonviral vector segment is expected to grow at the fastest rate during the forecast period.

Oncological problems, uncommon diseases, cardiovascular diseases, neurological disorders, infectious disease, and other applications are covered in the study. Because of the rising frequency of cancer globally and the increasing regulatory approval of gene therapy for cancer, the oncological diseases sector contributed the most to market growth. However, due to a growth in the number of clinical trials of gene therapies for the treatment of various disorders, the cardiovascular diseases segment is expected to develop at a profitable pace throughout the projection period.

Gene Therapy Market Key Players

The key players operating in the global gene therapy market include Adaptimmune Therapeutics Plc., Anchiano Therapeutics Ltd., Achieve Life Sciences, Inc., Adverum Biotechnologies, Inc., Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, Arbutus Biopharma Corporation, Audentes Therapeutics, Inc., AveXis, Inc., Bluebird Bio, Inc., Celgene Corporation, CRISPR Therapeutics AG, Editas Medicine, Inc., Editas Medicine, Inc., GlaxoSmithKline Plc., Intellia Therapeutics, Inc., Merck & Co., Inc., Novartis AG, REGENXBIO Inc., Spark Therapeutics, Inc., Sangamo Therapeutics, Inc., Uniqure N. V., Voyager Therapeutics, Inc. Other prominent players in the value chain (companies not profiled in the report) includes Amgen, Epeius Biotechnologies, Sanofi, Juno Therapeutics, and Advantagene.

• Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.
• Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
• Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

Who Should Buy? Or Key stakeholders

• Pharmaceutical Industry
• Chemical Industry
• Healthcare Industry
• Hospitals and Clinics
• Clinical Laboratories
• Investors
• Manufacturing companies
• Scientific Research and Development
• End user companies
• Others

Key Takeaways:

• The global gene therapy market size is projected to grow at a CAGR of 28% for the forecasted year.
• The gene silencing therapy accounted for the largest share of the type segment in overall gene therapy industry.
• The neurology segment dominated the therapeutic area segment in overall gene therapy industry.
• North America was the largest market for overall gene therapy industry in 2022 and also during the forecast period.
• A notable trend in gene therapy is the increasing number of approvals for products targeting genetic disorders, demonstrating its growing acceptance and efficacy.

Gene Therapy Market Regional Analysis

The global gene therapy market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

• North America: includes the US, Canada, Mexico
• Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
• Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
• South America: includes Brazil, Argentina and Rest of South America
• Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

[caption id="attachment_3747" align="alignnone" width="680"] Gene Therapy Market | Exactitude Consultancy[/caption]

Because of the high prevalence rate of cancer, the presence of high disposable income, and an increase in funding for R&D activities associated with gene therapy, North America accounted for the largest market share in the gene therapy market, and this trend is expected to continue during the forecast period. However, due to an increase in the number of persons susceptible to different chronic diseases, Asia-Pacific is predicted to expand the fastest throughout the projection period.

Key Market Segments: Gene Therapy Market

Gene Therapy Market By Vector Type, 2020-2029, (USD Million)

• Viral Vector
• Non-Viral Vector

Gene Therapy Market By Gene Type, 2020-2029, (USD Million)

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide
• Deficiency
• Growth Factors
• Receptors

Gene Therapy Market By Application, 2020-2029, (USD Million)

• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease

Gene Therapy Market By Region, 2020-2029, (USD Million)

• North America
• Europe
• Asia Pacific
• South America
• Middle East And Africa

Important Countries In All Regions Are Covered.

Key Question Answered

• What are the growth opportunities related to the adoption of gene therapy across major regions in the future?
• What are the new trends and advancements in the gene therapy market?

• Which product categories are expected to have highest growth rate in the gene therapy market?

• Which are the key factors driving the gene therapy market?
• What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?

1. Introducción
   
   
   
   1. Definición de mercado
   
   
   2. Segmentación del mercado
   
   
   3. Cronología de la investigación
   
   
   4. Supuestos y limitaciones
   
   
   
   


2. Metodología de la investigación
   
   
   
   1. Minería de datos
      
      
      
      1. Investigación secundaria
      
      
      2. Investigación primaria
      
      
      3. Subject-Matter Experts’ Advice
      
      
      
      
   
   
   2. Quality Checks
      
      
      
      1. Final Review
      
      
      
      
   
   
   3. Data Triangulation
      
      
      
      1. Bottom-Up Approach
      
      
      2. Top-Down Approach
      
      
      3. Research Flow
      
      
      
      
   
   
   4. Data Sources
   
   
   
   


3. Executive Summary


4. Market Overview
   
   
   
   1. Global Gene Therapy Market Outlook
      
      
      
      1. Market Drivers
      
      
      2. Market Restraints
      
      
      3. Market Opportunities
      
      
      
      
   
   
   2. Impact of Covid-19 On Gene Therapy Market
   
   
   3. Porter’s five forces model
      
      
      
      1. Threat from new entrants
      
      
      2. Threat from substitutes
      
      
      3. Bargaining power of suppliers
      
      
      4. Bargaining power of customers
      
      
      5. Degree of competition
      
      
      
      
   
   
   4. Industry value chain Analysis
   
   
   
   


5. Global Gene Therapy Market by Vector Type (USD Million)
   
   
   
   1. Viral Vector
   
   
   2. Non-Viral Vector
   
   
   
   


6. Global Gene Therapy Market by Gene Type (USD Million)
   
   
   
   1. Antigen
   
   
   2. Cytokine
   
   
   3. Tumor Suppressor
   
   
   4. Suicide
   
   
   5. Deficiency
   
   
   6. Growth Factors
   
   
   7. Receptors
   
   
   
   


7. Global Gene Therapy Market by Application (USD Million)
   
   
   
   1. Oncological Disorders
   
   
   2. Rare Diseases
   
   
   3. Cardiovascular Diseases
   
   
   4. Neurological Disorders
   
   
   5. Infectious Disease
   
   
   
   


8. Global Gene Therapy Market by Region (USD Million)
   
   
   
   1. North America
      
      
      
      1. US
      
      
      2. Canada
      
      
      3. Mexico
      
      
      
      
   
   
   2. South America
      
      
      
      1. Brazil
      
      
      2. Argentina
      
      
      3. Colombia
      
      
      4. Rest Of South America
      
      
      
      
   
   
   3. Europe
      
      
      
      1. Germany
      
      
      2. UK
      
      
      3. France
      
      
      4. Italy
      
      
      5. Spain
      
      
      6. Russia
      
      
      7. Rest Of Europe
      
      
      
      
   
   
   4. Asia Pacific
      
      
      
      1. India
      
      
      2. China
      
      
      3. Japan
      
      
      4. South Korea
      
      
      5. Australia
      
      
      6. South-East Asia
      
      
      7. Rest Of Asia Pacific
      
      
      
      
   
   
   5. Middle East and Africa
      
      
      
      1. UAE
      
      
      2. Saudi Arabia
      
      
      3. South Africa
      
      
      4. Rest Of Middle East and Africa
      
      
      
      
   
   
   
   


9. Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
   
   
   
   1. Adaptimmune Therapeutics Plc.
   
   
   2. Anchiano Therapeutics Ltd.
   
   
   3. Achieve Life Sciences, Inc.
   
   
   4. Adverum Biotechnologies, Inc.
   
   
   5. Abeona Therapeutics Inc.
   
   
   6. Applied Genetic Technologies Corporation
   
   
   7. Arbutus Biopharma Corporation
   
   
   8. Audentes Therapeutics, Inc.
   
   
   9. AveXis, Inc.
   
   
   10. Bluebird Bio, Inc.
   
   
   11. Epeius Biotechnologies
   
   
   12. Sanofi *The Company List Is Indicative
   
   
   
   

 

LIST OF TABLES

TABLE 1                GLOBAL GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 2                GLOBAL GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 3                GLOBAL GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 4                GLOBAL GENE THERAPY MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 5                US GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 6                US GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 7                US GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 8               CANADA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 9                CANADA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 10             CANADA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 11             MEXICO GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 12             MEXICO GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 13             MEXICO GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 14             BRAZIL GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 15             BRAZIL GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16             BRAZIL GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 17             ARGENTINA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 18             ARGENTINA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 19             ARGENTINA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 20             COLOMBIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 21             COLOMBIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 22             COLOMBIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 23             REST OF SOUTH AMERICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 24             REST OF SOUTH AMERICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 25             REST OF SOUTH AMERICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 26             INDIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 27             INDIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 28             INDIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 29             CHINA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 30             CHINA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31             CHINA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 32             JAPAN GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 33             JAPAN GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 34             JAPAN GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 35             SOUTH KOREA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 36             SOUTH KOREA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 37             SOUTH KOREA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 38             AUSTRALIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 39             AUSTRALIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 40             AUSTRALIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 41             SOUTH-EAST ASIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 42             SOUTH-EAST ASIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 43             SOUTH-EAST ASIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 44             REST OF ASIA PACIFIC GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 45             REST OF ASIA PACIFIC GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46             REST OF ASIA PACIFIC GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 47             GERMANY GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 48             GERMANY GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 49             GERMANY GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 50             UK GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 51             UK GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 52             UK GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 53             FRANCE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 54             FRANCE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 55             FRANCE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 56             ITALY GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 57             ITALY GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 58             ITALY GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 59             SPAIN GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 60             SPAIN GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61             SPAIN GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 62             RUSSIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 63             RUSSIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 64             RUSSIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 65             REST OF EUROPE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 66             REST OF EUROPE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 67             REST OF EUROPE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 68             UAE GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 69             UAE GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 70             UAE GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 71             SAUDI ARABIA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 72             SAUDI ARABIA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 73             SAUDI ARABIA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 74             SOUTH AFRICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 75             SOUTH AFRICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76             SOUTH AFRICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

TABLE 77             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY VECTOR TYPE (USD MILLIONS) 2020-2029

TABLE 78             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 79             REST OF MIDDLE EAST AND AFRICA GENE THERAPY MARKET BY GENE TYPE (USD MILLIONS) 2020-2029

 

LIST OF FIGURES

FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL GENE THERAPY MARKET BY VECTOR TYPE, USD MILLION, 2019-2028

FIGURE 9             GLOBAL GENE THERAPY MARKET BY GENE TYPE, USD MILLION, 2019-2028

FIGURE 10           GLOBAL GENE THERAPY MARKET BY APPLICATION, USD MILLION, 2019-2028

FIGURE 11           GLOBAL GENE THERAPY MARKET BY REGION, USD MILLION, 2019-2028

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           NORTH AMERICA GENE THERAPY MARKET SNAPSHOT

FIGURE 14           EUROPE GENE THERAPY MARKET SNAPSHOT

FIGURE 15           ASIA PACIFIC GENE THERAPY MARKET SNAPSHOT

FIGURE 16           SOUTH AMERICA GENE THERAPY MARKET SNAPSHOT

FIGURE 17           MIDDLE EAST & AFRICA GENE THERAPY MARKET SNAPSHOT

FIGURE 18           ADAPTIMMUNE THERAPEUTICS PLC.: COMPANY SNAPSHOT

FIGURE 19           ANCHIANO THERAPEUTICS LTD.: COMPANY SNAPSHOT

FIGURE 20           ACHIEVE LIFE SCIENCES, INC.: COMPANY SNAPSHOT

FIGURE 21           ADVERUM BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT

FIGURE 22           ABEONA THERAPEUTICS INC.: COMPANY SNAPSHOT

FIGURE 23           APPLIED GENETIC TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT

FIGURE 24           ARBUTUS BIOPHARMA CORPORATION: COMPANY SNAPSHOT

FIGURE 25           AUDENTES THERAPEUTICS, INC.: COMPANY SNAPSHOT

FIGURE 26           AVEXIS, INC.: COMPANY SNAPSHOT

FIGURE 27           BLUEBIRD BIO, INC.: COMPANY SNAPSHOT

FIGURE 28           EPEIUS BIOTECHNOLOGIES: COMPANY SNAPSHOT